Dopamine receptor gene expression in hippocampus is differentially regulated by the NMDA receptor antagonist MK-801

European Journal of Pharmacology

Volumn 306, Issue 1-3, 1996, Pages 257-264

  Healy, Daniel J ^a   Meador Woodruff, James H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

dentate gyrus; dizocilpine; glutamate; in situ hybridization; schizophrenia

Indexed keywords

DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

EID: 0030582103     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00204-X     Document Type: Article

References (54)

1. Akbarian, S., A, Viñuela, J.J. Kim, S.G. Potkin, W.E. Bunney and E.G. Jones, 1993, Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development, Arch. Gen. Psychiatry 50, 178.
2. Altschuler, L.L., M.F. Casanova, T.E. Goldberg and J.E. Kleinman, 1990, The hippocampus and parahippocampus in schizophrenic, suicide, and control brains. Arch. Gen. Psychiatry 47, 1029.
3. Araneda, R. and G. Bustos, 1989, Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra, J. Neurochem. 52, 962.
4. Benes, F.M., I. Sorensen and E. Bird, 1991, Reduced neuronal size in posterior hippocampus of schizophrenic patients, Schizophr. Bull. 17, 597.
5. Bogerts, B., E. Meertz and R. Schonfeldt-Bausch, 1985, Basal ganglia and limbic system pathology in schizophrenia: A morphometric study of brain volume and shrinkage, Arch. Gen. Psychiatry 42, 784.
6. Carlsson, M. and A. Carlsson, 1990, Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13 272.
7. +: possible action at the dopamine transporter, Br. J. Pharmacol. 114, 315
8. Clow, D.W. and K. Jhamandas, 1989, Characterization of L-glutamate action on the release of endogenous dopamine from rat caudate-putamen, J. Pharmacol. Exp. Ther. 248, 722.
9. Davis, K.L., R.S. Kahn, G. Ko and M. Davidson, 1991, Dopamine in schizophrenia: a review and reconceptualization, Am. J. Psychiatry 148, 1474.
10. Deakin, J.F., P. Slater, M.D. Simpson, A.C. Gilchrist, W.J. Skan, M.C. Royston, G.P. Reynolds and A.J. Cross, 1989, Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia, J. Neurochem. 52, 1781.
11. Domino, E.F. and E.D. Luby. 1973, Abnormal mental states induced by phencyclidine as a model of schizophrenia, in: Psychopathology and Psychopharmacology, eds. J.O. Cole, A.M. Freedman and A.J. Friedhoff (Johns Hopkins University Press, Baltimore, MD) p. 37.
12. Eastwood, S.L., B. McDonald, P.W.J. Burnet, J.P. Beckwith, R.W. Kerwin and P.J. Harrison, 1995, Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia, Mol. Brain Res. 29, 211.
13. Ferraro, G., N. Vella, P. Sardo, G. Caravaglios, M. Sabatino and V. La Grutta, 1991, Dopaminergic control of feline hippocampal epilepsy: A nigrohippocampal pathway, Neurosci, Lett. 123, 41.
14. Gasbarri, A., C. Verney, R. Innocenzi, E. Campana and C. Pacitti, 1994, Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study, Brain Res. 668, 71.
15. Gerfen, C.R., 1992, The neostriatal mosaic: multiple levels of compartmental organization, J. Neural Transm. Suppl. 36, 43.
16. Giorguieff, M., M.L. Kernel and J. Glowinski, 1977, Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices, Neurosci. Lett. 6, 73.
17. Goff, D.C., G. Tsai, D.S. Manoach and J.T. Coyle, 1995, Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia, Am. J. Psychiatry 152, 1213.
18. Goldsmith, S.K. and J.N. Joyce, 1994. Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers, Hippocampus 4, 354.
19. Grace, A.A., 1993, Cortical regulation of subcortical systems and its possible relevance to schizophrenia, J. Neural Trans. 91, 111.
20. Gruzelier, J., K. Seymour, L. Wilson. A. Jolley and S. Hirsch, 1988. Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders, Arch. Gen. Psychiatry 45, 623.
21. Harrison, P.J., D. McLaughlin and R.W. Kerwin, 1991, Decreased hippocampal expression of a glutamate receptor gene in schizophrenia, Lancet 337, 450.
22. Healy, D.J. and J.H. Meador-Woodruff, 1996, Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems, Brain Res. 708, 38.
23. Hollmann, M. and S. Heinemann, 1994, Cloned glutamate receptors. Annu Rev. Neurosci. 17, 31.
24. Ishimaru, M., A. Kurumaji and M. Toru, 1994, Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis, Biol. Psychiatry 35, 84.
25. Itil, T., A. Keskiner, N. Kiremitci and J.M.C. Holden, 1967. Effect of phencyclidine in chronic schizophrenia, Can. J. Psychiatry 12, 209.
26. Javitt, D.C. and S.R. Zukin, 1991, Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiatry 148, 1301.
27. Javitt, D.C., I. Zylberman, S.R. Zukin, U. Heresco-Levy and J.P. Lindenmayer, 1994, Amelioration of negative symptoms in schizophrenia by glycine. Am. J. Psychiatry 151, 1234.
28. Kerwin, R.W. and R.M. Murray, 1992, A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia. Schizophr. Res. 7, 1.
29. Kerwin, R., S. Patel, B. Meldrum, C. Czudek and G.P. Reynolds, 1988, Assymetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia, Lancet 331, 583.
30. Kerwin, R., S. Patel and B. Meldrum, 1990, Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain postmortem, Neuroscience 39, 25.
31. Kolb, B. and I.Q. Whishaw, 1983, Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurological patients, J. Nerv. Ment. Dis. 171, 435.
32. Kovelman, J.A. and A.B. Scheibel, 1984, A neurohistological correlate of schizophrenia, Biol. Psychiatry 19, 1601.
33. Krieckhaus, E.E., J.W. Donahoe, and M.A. Morgan, 1992, Paranoid schizophrenia may be caused by dopamine hyperactivity of CA1 hippocampus, Biol. Psychiatry 31, 560-570.
34. Krystal, J.H., L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, J.D. Bremner, G.R. Heninger, M.B. Bowers, Jr. and D.S. Charney, 1994, Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive and neuroendocrine responses, Arch. Gen. Psychiatry 51, 199.
35. Luby, E.D., J.S. Gottlieb, B.D. Cohen, G. Rosenbaum and E.F. Domino, 1962. Model psychoses and schizophrenia, Am. J. Psychiatry 119, 61.
36. Meador-Woodruff, J.H., A. Mansour, D.J. Healy, R. Kuehn, Q.-Y. Zhou, J.R. Bunzow, H. Akil, O. Civelli and S.J. Watson, 1991, Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 5, 231.
37. Meador-Woodruff, J.H., S. Damask and S.J. Watson, 1992, Differential expression of autoreceptors in ascending dopamine systems of human brain, Proc. Natl. Acad. Sci. USA 91, 8297.
38. Meador-Woodruff, J.H., A. Mansour, D.K. Grandy, S. Damask, O. Civelli and S.J. Watson, 1994, Distribution of D5 dopamine receptor mRNA in rat brain, Neurosci. Lett. 145, 209.
39. Murase, S., J.M. Mathe, J. Grenhoff and T.H. Svensson, 1993, Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization, J. Neural Transm. Gen. Sect. 91, 13.
40. 3H]kainic acid binding in the prefrontal cortex in schizophrenia, Neurosci. Lett. 40, 245.
41. Paxinos, G. and C. Watson, 1982, The Rat Brain in Stereotaxic Coordinates (Academic Press, New York).
42. 3H-dopamine from rat striatal slices, Brain Res. 157, 391.
43. Scatton, B., H. Simon, M. Le Moal and S. Bischoff, 1980, Origin of dopaminergic innervation of the rat hippocampal formation, Neurosci. Lett. 18, 125.
44. Seeman, P., T. Lee, M. Chau-Wong and K. Wong, 1976, Antipsychotic drug doses and neuroleptic/dopamine receptors, Nature 261, 717.
45. Sherman, A.D., T.S. Hegwood, S. Baruah and R. Waziri, 1991, Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics, Biol. Psychiatry 30, 1191.
46. Smialowski, A., 1990, Inhibition of low calcium induced epileptiform discharges in the hippocampus by dopamine D1 receptor agonist, SKF 38393. Brain Res. 528, 148.
47. Snyder, S., 1976, The dopamine hypothesis in schizophrenia: focus on the dopamine receptor, Am. J. Psychiatry 133, 197.
48. 3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses?. Neurochem. Res. 18, 219.
49. Swanson, L.W,. 1982, The projections of the ventral tegmental area and adjacent regions, a combined fluorescent retrograde tracer and immunofluorescence study in the rat, Brain. Res. Bull. 9, 321.
50. Tamminga, C.A., G.K. Thaker, R. Buchanan, B. Kirkpatrick, L.D. Alphs, T.N. Chase and W.T. Carpenter, 1992, Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch. Gen. Psychiatry 49, 522.
51. Weinberger, D.R., 1987, Implications of normal brain development for the pathogenesis of schizophrenia, Arch. Gen. Psychiatry 44, 660.
52. Whitton, P.S., C.S. Biggs, B.R. Pearce, and L.J. Fowler, 1992, Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis, Neurosci. Lett. 42, 5.
53. Whitton, P.S., S. Maione, C.S. Biggs and L.J. Fowler, 1994, N-Methyl-D-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo, Brain Res. 635, 312.
54. Wolkin, A., M. Sanfilipo, B. Angrist, E. Duncan, S. Wieland, A.P. Wolf, J.D. Brodie, T.B. Cooper, E. Laska and J.P. Rotrosen, 1994, Acute D-amphetamine challenge in schizophrenia: Effects on cerebral glucose utilization and clinical symptomatology, Biol. Psychiatry 36, 317.